Should electroconvulsive therapy be more routinely used in the treatment of depression in elderly patients with cognitive disturbances?

Neuropsychiatry

Volumn 1, Issue 5, 2011, Pages 403-407

  Hausner, Lucrezia ^a   Sartorius, Alexander ^a   Kranaster, Laura ^a   Förlich, Lutz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; GALANTAMINE; KETAMINE; MEMANTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALZHEIMER DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DEPRESSION; ELECTROCONVULSIVE THERAPY; GERIATRIC DISORDER; HUMAN; MEMORY DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW;

EID: 84876511023     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.11.48     Document Type: Review

References (32)

1. Lebowitz BD, Pearson JL, Schneider LS et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA 278, 1186-1190 (1997). (Pubitemid 27422429)
2. Teresi J, Abrams R, Holmes D et al. Prevalence of depression and depression recognition in nursing homes. Soc. Psychiatry Psychiatr. Epidemiol. 36, 613-620 (2001). (Pubitemid 34093048)
3. Serby M, Yu M. Overview: depression in the elderly. Mt Sinai J. Med. 70, 38-44 (2003). (Pubitemid 36041431)
4. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst. Rev. (1), CD003491 (2006).
5. O'Brien JT, Firbank MJ, Krishnan MS et al. on behalf of the LADIS Group. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am. J. Geriatr. Psychiatry 14, 834-841 (2006). (Pubitemid 44556477)
6. Sheline YI, Barch DM, Garcia K et al. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol. Psychiatry 60, 58-65 (2006).
7. Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J. Am. Geriatr. Soc. 44(9), 1078-1081 (1996). (Pubitemid 26304552)
8. Espiritu DAV, Rashid H, Mast BT, Fitzgerald J, Steinberg J, Lichtenberg PA. Depression, cognitive impairment and function in Alzheimer's disease. Int. J. Geriatr. Psychiatry 16, 1098-1103 (2001). (Pubitemid 33089274)
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7), 939-944 (1984). (Pubitemid 14076461)
10. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6(8), 734-746 (2007). (Pubitemid 47058377)
11. Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9(11), 1118-1127 (2010).
12. Wilkins CH, Mathews J, Sheline YI. Late life depression with cognitive impairment: evaluation and treatment. Clin. Interv. Aging 4, 51-57 (2009).
13. Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA 298, 330-332 (2007).
14. Hausner L, Damian M, Sartorius A, Frölich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J. Clin. Psychiatry 72(1), 91-97 (2011).
15. Wurff van der FB, Stek ML, Hoogendijk WL, Beekman AT. The efficacy and safety of ECT in depressed older adults: a literature review. Int. J. Geriatr. Psychiatry 18, 894-904 (2003). (Pubitemid 37294851)
16. Mulsant BH, Rosen J, Thornton JE, Zubenko GS. A prospective naturalistic study of electroconvulsive therapy in late-life depression. J. Geriatr. Psychiatry Neurol. 4(1), 3-13 (1991).
17. Salzman C, Wong E, Wright BC. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol. Psychiatry 52, 265-284 (2002). (Pubitemid 35232093)
18. Tew JD Jr, Mulsant BH, Haskett RF et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am. J. Psychiatry 156, 1865-1870 (1999).
19. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am. J. Psychiatry 152(7), 995-1001 (1995).
20. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch. Gen. Psychiatry 57(6), 581-590 (2000). (Pubitemid 30349438)
21. Agelink MW, Andrich J, Postert T et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein J. Neurol. Neurosurg. Psychiatry 71(3), 394-396 (2001). (Pubitemid 32772541)
22. Hihn H, Baune BT, Michael N, Markowitsch H, Arolt V, Pfleiderer B. Memory performance in severely depressed patients treated by electroconvulsive therapy. ECT 22(3), 189-195 (2006). (Pubitemid 44379374)
23. Tielkes CE, Comijs HC, Verwijk E, Stek ML. The effects of ECT on cognitive functioning in the elderly: a review. Int. J. Geriatr. Psychiatry 23, 789-795 (2008).
24. Gardner BK, O'Connor DW. A review of the cognitive effects of electroconvulsive therapy in older adults. J. ECT 24(1), 68-80 (2008). (Pubitemid 351498645)
25. Goodman WK. Electroconvulsive therapy in the spotlight. N. Engl. J. Med. 364(19), 1785-1787 (2011).
26. Bayless JD, McCormick LM, Brumm MC, Espe-Pfeifer PB, Long JJ, Lewis JL. Pre-and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: relationship to premorbid abilities and symptom improvement. J. ECT 26(1), 47-52 (2010).
27. Rose D, Wykes T, Leese M, Bindman J, Fleischmann P. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 326(7403), 1363 (2003).
28. Bosboom PR, Deijen JB. Age-related cognitive effects of ECT and ECT-induced mood improvement in depressive patients. Depress. Anxiety 23(2), 93-101 (2006).
29. Matthews JD, Blais M, Park L et al. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study. J. Psychiatr. Res. 42(7), 526-531 (2008). (Pubitemid 351400483)
30. Zink M, Sartorius A, Lederbogen F, Henn FA. Electroconvulsive therapy in a patient receiving rivastigmine. J. ECT 18(3), 162-164 (2002). (Pubitemid 35192431)
31. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. 5, 160-170 (2006).
32. Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s00406-011-0205-7 (2011) (Epub ahead of print).